 |
|
 Since its foundation in 1957, SNBL Drug Safety Research Laboratories, Japan's
first preclinical contract research organization, has steadily expanded
and innovated to become the world's largest non-human primate drug safety
research facility.
SNBL has devised unique positioners (international patents) and techniques
for productive data capture from reduced numbers of primates with minimized
stress. SNBL has also developed disease models to investigate drug efficacy,
and is particularly proud of its arthritis model, an example of world-class
technology.
The facility has expanded with increasing demand and can initiate pharmaceutical
studies at short notice. SNBL is highly regarded for its responsiveness
and its wide range of techniques. SNBL offers juvenile studies in cynomolgus
and rhesus monkeys (age at first administration, 8-12 months), beagles
(3 weeks), and rats (5 days). Furthermore, SNBL offers studies in mature
and aged beagles and primates.
|
|
